Company news: Emyria; Cann Group; Creso Pharma; Cronos; MGC Pharma by Martin Lane April 14, 2022April 29, 2024 Emyria Emyria has begun dosing participants in a Phase 1 clinical trial assessing the safety and […]
GSK agreement ‘validates’ Satipharm strategy as Cann Group pins hopes on positive clinical trial by Steve Jones April 7, 2022April 29, 2024
Cann Group inks Satipharm deal with GSK Consumer Healthcare by Martin Lane April 6, 2022April 29, 2024
Satipharm among CBD products given green light by UK Food Standards Agency by Martin Lane April 1, 2022April 29, 2024
Don’t pump up cannabis as wonder cure for Covid, warns MCIA chair by Steve Jones February 24, 2022April 29, 2024
It’s been a long road, but Cann Group’s Mildura gamble might be about to pay off by Rhys Cohen February 23, 2022April 29, 2024
Veteran-owned cannabis firm unveils plan to support former comrades by Steve Jones February 17, 2022April 29, 2024
Over-the-counter race hots up as Cann Group prepares to recruit patients for sleep disturbance trial by Steve Jones February 16, 2022April 29, 2024